Go Back

Merabo Labs Private Limited

DealShare

U74999RJ2018PTC062179

Get Comprehensive Report

₹1,999.00 ₹3,998.00
Suggest Edit Last updated: Jan 17, 2025
Key Metrics
  • No. of Employees1467
  • Founded Year 2018
  • Company StagePrivate Limited Company
  • Total Funding₹2,995.79 Cr
  • Industry

  • Headquarter
  • Company StatusActive
About DealShare
A fast-growing e-commerce startup, DealShare is a hyperlocal online buying platform for multi-category consumer products focused on the new 'WhatsApp first' India. Their mission is to target the new 500Mn users from non-metro cities and rural market spaces who haven't shopped enough online and are uncomfortable on other platforms. These users are primarily on mobile & social media. DealShare makes it extremely easy for these users to buy in a couple of clicks, supported by vernacular browsing. Further, it allows the users to share deals with their friends and avail discounts if their friends purchase the products via the share link. It is a new retail model in which customers get products at cheaper than wholesale rates. The idea is around demand aggregation (C2B) of mass-market products using social virality, thereby significantly reducing operational costs. DealShare product catalogue includes fruits & vegetables, grocery items, beauty & wellness, baby care, pet care, fashion accessories, electronics, home décor etc.
Business Model

Dealshare is an inventory-led platform focused on grocery and essentials which manages the supply chain and logistics in bigger cities. Currently, it has a presence in 10 states and over 100 cities and is targeting to expand to 20 states and 300 cities and towns.

Top Competitors
ZE
ZeptoU52100MH2021PTC362722
BI
BigbasketU74130KA2010PTC052192
DU
DunzoU74900KA2014PTC075256
BL
BlinkitU74140HR2015FTC055568
DealShare Funding Details
Funding Highlights
Latest Funding RoundSeries E
Total Funding Raised₹2,995.79 Cr
No. of Investments Made0
Total No. of Acquisitions0
Lead Investors5
Investors
  • WestBridge, Alpha Wave, Tiger Global, Matrix Partners, Abu Dhabi Investment Authority
Funding Details
TheKredible's detailed funding report contains info about Funding raised by the company along with Lead Investors, Investors, Shareholding Strcuture, and its Investments & Acquisitions.
₹799.00 ₹1,598.00
Funding History
TheKredible's 'Funding History' report provides deep insights of Funding with list of Lead Investors
₹399.00 ₹798.00
Funding Per Year
A Funding report of the company's overall funding on yearly basis, segregated by the team TheKredible.
₹199.00 ₹398.00
DealShare Financial Details
Financial Highlights
FY 2023-24 Revenue₹600.46 Cr
FY 2023-24 Expenses₹768.18 Cr
FY 2023-24 Profit/Loss-₹167.73 Cr
Net Cash Flow From Operations-₹255.15 Cr
Full Financial Details
Detailed report containing info about Business Model, year-wise Financial Comparison, Ratio Analysis and detailed Revenue and Expense breakdowns.
₹799.00 ₹1,598.00
Financial Comparison
A detailed report of year-wise Financial Comparison of the company
₹430.00 ₹860.00
Revenue Breakdown
A report and breakdown of the company's year-wise revenue streams.
₹399.00 ₹798.00
Expense Breakdown
A report and breakdown of the company's year-wise expenditures.
₹399.00 ₹798.00
Shareholding Structure
Team at TheKredible has gone through several ROC filings and portrayed Shareholding Structure of the company.
₹499.00 ₹998.00
Financial Ratio
Analysis of Financial Ratios which gives quick insights about the company's profitability and capital efficiency.
₹199.00 ₹398.00
DealShare Key People
People Metrics
Current Core Team4
Board Members/Directors4

Core Team

RS
Rajat ShikharCo-Founder & CPO
SB
Sankar BoraCo-Founder & COO
KS
Kamaldeep SinghCEO
SM
Sourjyendu MeddaCo-Founder

Board Members/Directors

SS
Sandeep SinghalNominee Director
SM
Sourjyendu MeddaDirector
SB
Sankar BoraDirector
VR
Vineet RaoDirector
DealShare Documents

AY - 2018-19

Profit and Loss statement - DealShare - 2018-19.pdf
TheKredible's experts has summarized the Profit and Loss Statement of DealShare for FY 2018-19.
₹249.00 ₹498.00
Balance Sheet - DealShare - 2018-19.pdf
TheKredible's experts has summarized the Balance Sheet of DealShare for FY 2018-19.
₹249.00 ₹498.00

AY - 2019-20

Profit and Loss statement - DealShare - 2019-20.pdf
TheKredible's experts has summarized the Profit and Loss Statement of DealShare for FY 2019-20.
₹249.00 ₹498.00
Balance Sheet - DealShare - 2019-20.pdf
TheKredible's experts has summarized the Balance Sheet of DealShare for FY 2019-20.
₹249.00 ₹498.00

AY - 2020-21

Profit and Loss statement - DealShare - 2020-21.pdf
TheKredible's experts has summarized the Profit and Loss Statement of DealShare for FY 2020-21.
₹249.00 ₹498.00
Balance Sheet - DealShare - 2020-21.pdf
TheKredible's experts has summarized the Balance Sheet of DealShare for FY 2020-21.
₹249.00 ₹498.00

AY - 2021-22

Profit and Loss statement - DealShare - 2021-22.pdf
TheKredible's experts has summarized the Profit and Loss Statement of DealShare for FY 2021-22.
₹249.00 ₹498.00
Balance Sheet - DealShare - 2021-22.pdf
TheKredible's experts has summarized the Balance Sheet of DealShare for FY 2021-22.
₹249.00 ₹498.00

AY - 2022-23

Profit and loss statement - DealShare - 2022-23.pdf
TheKredible's experts has summarized the Profit and Loss Statement of DealShare for FY 2022-23
₹249.00 ₹498.00
Balance sheet - DealShare - 2022-23.pdf
TheKredible's experts has summarized the Balance Sheet of DealShare for FY 2022-23
₹249.00 ₹498.00

AY - 2023-24

Profit and loss statement - DealShare - 2023-24.pdf
TheKredible's experts has summarized the Profit and Loss Statement of DealShare for FY 2023-24
₹249.00 ₹498.00
Balance sheet - DealShare - 2023-24.pdf
TheKredible's experts has summarized the Balance Sheet of DealShare for FY 2023-24
₹249.00 ₹498.00

Subscribe to our newsletter to stay updated

Weekly Funding Reports
Funding Report
Weekly Funding Report [ 27 Jan- Feb 01]
Montly Funding Reports
Funding Report
Indian startups raise $1.76 Bn in January

Get your Customised Report

With an exclusive 20% off on your order

Latest Industry Reports
Industry Report
HealthTech’s Rebound: After a Downturn, HealthTech...